ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Similarities and Differences Between HFmrEF and HFpEF

Li, Peixin; Zhao, Hengli; Zhang, Jianyu; Ning, Yunshan; Tu, Yan; Xu, Dingli*; Zeng, Qingchun*佛山市第一人民医院; 南方医科大学
Frontiers in Cardiovascular Medicine2021-9-20DOI: 10.3389/fcvm.2021.678614
14被引5阅读
引用收藏
分享

摘要

The new guidelines classify heart failure (HF) into three subgroups based on the ejection fraction (EF): HF with reduced EF (HFrEF), HF with mid-range EF (HFmrEF), and HF with preserved EF (HFpEF). The new guidelines regarding the declaration of HFmrEF as a unique phenotype have achieved the goal of stimulating research on the basic characteristics, pathophysiology, and treatment of HF patients with a left ventricular EF of 40-49%. Patients with HFmrEF have more often been described as an intermediate population between HFrEF and HFpEF patients; however, with regard to etiology and clinical indicators, they are more similar to the HFrEF population. Concerning clinical prognosis, they are closer to HFpEF because both populations have a good prognosis and quality of life. Meanwhile, growing evidence indicates that HFmrEF and HFpEF show heterogeneity in presentation and pathophysiology, and the emergence of this heterogeneity often plays a crucial role in the prognosis and treatment of the disease. To date, the exact mechanisms and effective treatment strategies of HFmrEF and HFpEF are still poorly understood, but some of the current evidence, from observational studies and post-hoc analyses of randomized controlled trials, have shown that patients with HFmrEF may benefit more from HFrEF treatment strategies, such as beta-blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, mineralocorticoid receptor antagonists, and sacubitril/valsartan. This review summarizes available data from current clinical practice and mechanistic studies in terms of epidemiology, etiology, clinical indicators, mechanisms, and treatments to discuss the potential association between HFmrEF and HFpEF patients.

学科与关键词

关键词
heart failureheart failure with mid-range ejection fractionheart failure with preserved ejection fractionheterogeneitycardiac abnormality
相关
加载中…
  • Heart Failure With Mid-range Ejection Fraction: A Distinctive Subtype or a Transitional Stage
    Zhou, Qing; Li, Peixin; Zhao, Hengli; Xu, Xingbo; Li, Shaoping; Zhao, Jing; Xu, Dingli*; Zeng, Qingchun*Frontiers in Cardiovascular Medicine, 2021, 8: 678121.被引 7
  • A Universal New Definition of Heart Failure With Improved Ejection Fraction for Patients With Coronary Artery Disease
    Huang, Haozhang; Liu, Jin; Lei, Min; Yang, Zhou; Bao, Kunming; Li, Qiang; Lai, Wenguang; Wang, Bo; He, Yibo; Chen, Shiqun; Ou, Chun-Quan; Abudukerimu, Maimaitiaili; Hu, Yuying; Tan, Ning*; Chen, Jiyan*; Liu, Yong*Frontiers in Physiology, 2021, 12: 770650.被引 4
  • 射血分数保留的心力衰竭的研究现状
    邰玉玲; 马晶茹沈阳医学院学报, 2019, (06): 549-553.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Cardiovascular Medicine
发表日期
2021-09-20
卷期
第 8 卷
页码
678614
DOI
10.3389/fcvm.2021.678614
期刊收录
NSL
期刊等级
3区
成果收录
SCIE
资助标注
Science and Technology Program of Guangzhou [201804010086, 201707020012]; National Natural Science Foundation of China [82070403, 81770386]; Frontier Research Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory [2018GZR110105001]; Youth Science and Technology Innovation Talent of Guangdong TeZhi Plan [2019TQ05Y136]

作者

  • L

    Li, Peixin (第一作者)

    southern med univ

  • Z

    Zhao, Hengli

    southern med univ

查看全部 7 位作者收起作者
  • Z

    Zhang, Jianyu

    foshan first peoples hosp

  • N

    Ning, Yunshan

    southern med univ

  • T

    Tu, Yan

    southern med univ

  • X

    Xu, Dingli (通讯)

    southern med univ

  • Z

    Zeng, Qingchun (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417